{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:58:03Z","timestamp":1784901483959,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.omtm.2020.11.019","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T21:32:55Z","timestamp":1606944775000},"page":"716-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The microRNA cluster miR-30b\/-30d prevents tumor cell switch from an epithelial to a mesenchymal-like phenotype in GBC"],"prefix":"10.1016","volume":"20","author":[{"given":"Kang","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.11.019_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11912-018-0664-3","article-title":"Updates on gallbladder cancer management","volume":"20","author":"Zaidi","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.omtm.2020.11.019_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omtm.2020.11.019_bib3","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omtm.2020.11.019_bib4","doi-asserted-by":"crossref","first-page":"13914","DOI":"10.18632\/oncotarget.4227","article-title":"MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtm.2020.11.019_bib5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3748\/wjg.v22.i5.1787","article-title":"MicroRNA aberrations: an emerging field for gallbladder cancer management","volume":"22","author":"Chandra","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omtm.2020.11.019_bib6","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.2174\/1568026619666181120121830","article-title":"MicroRNAs as therapeutic agents: the future of the battle against cancer","volume":"18","author":"Biswas","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.omtm.2020.11.019_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692249","article-title":"MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer","volume":"39","author":"Yang","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omtm.2020.11.019_bib8","doi-asserted-by":"crossref","first-page":"78640","DOI":"10.18632\/oncotarget.12693","article-title":"The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtm.2020.11.019_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.omtm.2020.11.019_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2478\/s11658-014-0199-z","article-title":"miR-30b is involved in methylglyoxal-induced epithelial-mesenchymal transition of peritoneal mesothelial cells in rats","volume":"19","author":"Liu","year":"2014","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.omtm.2020.11.019_bib11","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/IGC.0000000000000546","article-title":"miR-30d blocked transforming growth factor \u03b21-induced epithelial-mesenchymal transition by targeting snail in ovarian cancer cells","volume":"25","author":"Ye","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.omtm.2020.11.019_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccr.2011.05.027","article-title":"miR-30b\/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis","volume":"20","author":"Gaziel-Sovran","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtm.2020.11.019_bib13","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.bbagen.2013.05.003","article-title":"Analysis of SEMA6B gene expression in breast cancer: identification of a new isoform","volume":"1830","author":"D\u2019Apice","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2020.11.019_bib14","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2011-03-341388","article-title":"Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling","volume":"118","author":"Kigel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.11.019_bib15","first-page":"1849","article-title":"miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer","volume":"7","author":"Letelier","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.omtm.2020.11.019_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.prp.2018.10.013","article-title":"miR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2","volume":"215","author":"Hua","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.omtm.2020.11.019_bib17","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.3892\/mmr.2017.7520","article-title":"Decreased expression of hsa-miR-372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omtm.2020.11.019_bib18","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.2147\/IJN.S131516","article-title":"Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner","volume":"12","author":"Qin","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.omtm.2020.11.019_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4149\/neo_2018_170217N118","article-title":"MicroRNA-30b inhibits non-small cell lung cancer cell growth by targeting the epidermal growth factor receptor","volume":"65","author":"Qi","year":"2018","journal-title":"Neoplasma"},{"key":"10.1016\/j.omtm.2020.11.019_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/path.4309","article-title":"MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2","volume":"232","author":"Liao","year":"2014","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.omtm.2020.11.019_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mc.22799","article-title":"LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma","volume":"57","author":"He","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.omtm.2020.11.019_bib22","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.7150\/jca.25006","article-title":"MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells","volume":"9","author":"Xiong","year":"2018","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omtm.2020.11.019_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biochi.2017.10.027","article-title":"Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma","volume":"146","author":"Wang","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.omtm.2020.11.019_bib24","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3892\/or.2017.5405","article-title":"MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post-transcriptional regulation of enhancer of zeste homolog 2","volume":"37","author":"Xie","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omtm.2020.11.019_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2015.03.041","article-title":"MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer","volume":"362","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omtm.2020.11.019_bib26","doi-asserted-by":"crossref","first-page":"e5679","DOI":"10.1097\/MD.0000000000005679","article-title":"Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships","volume":"96","author":"Feng","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 20","key":"10.1016\/j.omtm.2020.11.019_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12859-018-2536-0","article-title":"MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers","volume":"19","author":"Tran","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.omtm.2020.11.019_bib28","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3892\/mmr.2017.6709","article-title":"Synergistic regulatory effects of microRNAs on brain glioma cells","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omtm.2020.11.019_bib29","first-page":"284","article-title":"The role of axon guidance factor semaphorin 6B in the invasion and metastasis of gastric cancer","volume":"41","author":"Ge","year":"2013","journal-title":"J.\u00a0Int. Med. Res."},{"key":"10.1016\/j.omtm.2020.11.019_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.critrevonc.2015.05.015","article-title":"Genetic alteration regulated by microRNAs in biliary tract cancers","volume":"96","author":"Wang","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.omtm.2020.11.019_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.scr.2015.06.004","article-title":"Novel surface markers directed against adult human gallbladder","volume":"15","author":"Galivo","year":"2015","journal-title":"Stem Cell Res. (Amst.)"},{"key":"10.1016\/j.omtm.2020.11.019_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.scr.2014.12.003","article-title":"Identification of a candidate stem cell in human gallbladder","volume":"14","author":"Manohar","year":"2015","journal-title":"Stem Cell Res. (Amst.)"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:28:08Z","timestamp":1762421288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120302461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"alternative-id":["S2329050120302461"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.11.019","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The microRNA cluster miR-30b\/-30d prevents tumor cell switch from an epithelial to a mesenchymal-like phenotype in GBC","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}